Proposed Data Collection Submitted for Public Comment and Recommendations, 82896-82897 [2023-26085]
Download as PDF
<![CDATA[
82896
Federal Register / Vol. 88, No. 226 / Monday, November 27, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–0931; Docket No. CDC–2023–
0094]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
SUMMARY: The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Blood Lead Surveillance System
(BLSS). The National Center for
Environmental Health (NCEH) is leading
a three-year Extension for two CDC
information collections, one for
childhood blood lead surveillance by
NCEH and another for adult blood lead
surveillance by the National Institute for
Occupational Safety and Health
(NIOSH).
CDC must receive written
comments on or before January 26,
2024.
DATES:
You may submit comments,
identified by Docket No. CDC–2023–
0094 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:43 Nov 24, 2023
Jkt 262001
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Blood Lead Surveillance System
(BLSS) (OMB Control No. 0920–0931,
Exp. 7/31/2024)—Extension—National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
This is a request for a three-year
extension for an existing Paperwork
Reduction Act (PRA) clearance titled
‘‘Blood Lead Surveillance System
(BLSS)’’ (OMB Control No. 0920–0931;
Exp. 7/31/2024). The National Center
for Environmental Health (NCEH) is
leading this Information Collection
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Request (ICR) for two Centers for
Disease Control and Prevention (CDC)
collections, one for childhood blood
lead surveillance by NCEH and another
for adult blood lead surveillance by the
National Institute for Occupational
Safety and Health (NIOSH).
The goal of the NCEH Childhood
Blood Lead Surveillance (CBLS)
Program is to support blood lead
screening and to promote primary
prevention of exposure to lead. Also, the
CBLS Program supports secondary
prevention of adverse health effects
when lead exposures occur in children,
through improved program management
and oversight in respondent
jurisdictions. The goal of the NIOSH
Adult Blood Lead Epidemiology and
Surveillance (ABLES) Program is to
build state capacity for adult blood lead
surveillance programs to measure trends
in adult blood lead levels and to prevent
lead over-exposures.
NCEH has a five-year cooperative
agreement, titled ‘‘Childhood Lead
Poisoning Prevention and Surveillance
of Blood Lead Levels in Children’’
(Funding Opportunity Announcement
[FOA] No. CDC–RFA–EH21–2102). The
first two years of this ICR will extend
from FY24, through FY26, and thus will
be covered for two-thirds of the ICR’s
three-year approval period, while
funding for the third year of this ICR
will be determined in the future. Data
submission is voluntary and completed
through data sharing agreements with
state agencies or their bona fide agents.
Blood lead surveillance over the
human lifespan is covered under this
single ICR, specifically for children
younger than 16 years through CBLS at
NCEH, and for adults 16 years and
older, through ABLES at NIOSH. Over
the past several decades there have been
substantial efforts in environmental lead
abatement, improved protection from
occupational lead exposure, and a
reduction in the prevalence of
population blood lead levels (BLLs) over
time. The U.S. population BLLs have
substantially decreased over the last
four decades. For example, the CDC has
reported the 1976–1980 U.S. mean BLL
in children six months to five years was
16.0 micrograms per deciliter (mcg/dL),
and 14.1 mcg/dL among adults 18 to 74
years. More recently, the CDC reported
the 2009–2010 U.S. BLL geometric
means among children ages one to five
years and among adults 20 years and
older as 1.2 mcg/dL for both age groups.
In 2012, the National Toxicology
Program (NTP) concluded that there is
sufficient evidence that even BLLs less
than 5.0 mcg/dL are associated with
adverse health effects in both children
and adults. Despite the reduction in the
E:\FR\FM\27NON1.SGM
27NON1
82897
Federal Register / Vol. 88, No. 226 / Monday, November 27, 2023 / Notices
overall population BLL over four
decades, lead exposures continue to
occur at unacceptable levels for
individuals in communities and
workplaces across the nation.
Surveillance will continue through
CBLS and ABLES to identify
individuals with BLLs greater than most
children who may need follow-up.
Surveillance can also help prioritize
communities for primary prevention of
lead exposure and expanding blood lead
testing. As of October 2021, NCEH
defines its Blood Lead Reference Value
(BLRV) for children at 3.5 mcg/dL.
NIOSH defines an elevated BLLs as
greater than or equal to 5.0 mcg/dL for
adults.
Respondents are defined as state,
local, and territorial health departments
with lead poisoning prevention
programs. The estimated annual time
burden for NCEH CBLS is 1,058 hours.
The estimated annual time burden for
NIOSH ABLES is 280 hours. In total,
CDC is requesting approval for a total
annual time burden of 1,338 hours.
There is no cost to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average burden
per response
(in hours)
CBLS Variables (ASCII Text Files) .....
CBLS Aggregate Records Form
(Excel).
ABLES Case Records Form and Brief
Narrative Report.
ABLES Aggregate Records Form and
Brief Narrative Report.
66
1
4
1
4
2
1,056
2
32
1
8
256
8
1
3
24
..............................................................
....................
........................
..........................
1,338
Type of
respondents
Form name
State, Local and Territorial Health Departments, or their Bona Fide
Agents.
Total ..............................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–26085 Filed 11–24–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–0260]
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Health Hazard
Evaluations/Technical Assistance and
Emerging Problems’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on August 1,
2023 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
VerDate Sep<11>2014
17:43 Nov 24, 2023
Jkt 262001
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Total
burden
(in hours)
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Health Hazard Evaluations/Technical
Assistance and Emerging Problems
(OMB Control No. 0920–0260, Exp. 3/
31/2024)—Revision—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
In accordance with its mandates
under the Occupational Safety and
Health Act of 1970 and the Federal
Mine Safety and Health Act of 1977,
NIOSH responds to requests for a Health
Hazare Evaluation (HHE) to identify
chemical, biological or physical hazards
in workplaces throughout the United
States. Each year, NIOSH receives
approximately 250 such requests
although that number has been lower in
recent years presumably due to the
COVID–19 pandemic. Most HHE
requests come from workplaces in the
following industrial sectors: services,
manufacturing, health and social
services, transportation, and
construction.
A printed HHE request form is
available in English and in Spanish. The
form is also available on the internet
and differs from the printed version
only in format and in the fact that it can
be submitted directly from the website.
The request form takes an estimated 12
minutes to complete. The form provides
the mechanism for employees,
E:\FR\FM\27NON1.SGM
27NON1
]]>Agencies
[Federal Register Volume 88, Number 226 (Monday, November 27, 2023)]
[Notices]
[Pages 82896-82897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-26085]
[[Page 82896]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-0931; Docket No. CDC-2023-0094]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Blood Lead Surveillance System
(BLSS). The National Center for Environmental Health (NCEH) is leading
a three-year Extension for two CDC information collections, one for
childhood blood lead surveillance by NCEH and another for adult blood
lead surveillance by the National Institute for Occupational Safety and
Health (NIOSH).
DATES: CDC must receive written comments on or before January 26, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0094 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Blood Lead Surveillance System (BLSS) (OMB Control No. 0920-0931,
Exp. 7/31/2024)--Extension--National Center for Environmental Health
(NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
This is a request for a three-year extension for an existing
Paperwork Reduction Act (PRA) clearance titled ``Blood Lead
Surveillance System (BLSS)'' (OMB Control No. 0920-0931; Exp. 7/31/
2024). The National Center for Environmental Health (NCEH) is leading
this Information Collection Request (ICR) for two Centers for Disease
Control and Prevention (CDC) collections, one for childhood blood lead
surveillance by NCEH and another for adult blood lead surveillance by
the National Institute for Occupational Safety and Health (NIOSH).
The goal of the NCEH Childhood Blood Lead Surveillance (CBLS)
Program is to support blood lead screening and to promote primary
prevention of exposure to lead. Also, the CBLS Program supports
secondary prevention of adverse health effects when lead exposures
occur in children, through improved program management and oversight in
respondent jurisdictions. The goal of the NIOSH Adult Blood Lead
Epidemiology and Surveillance (ABLES) Program is to build state
capacity for adult blood lead surveillance programs to measure trends
in adult blood lead levels and to prevent lead over-exposures.
NCEH has a five-year cooperative agreement, titled ``Childhood Lead
Poisoning Prevention and Surveillance of Blood Lead Levels in
Children'' (Funding Opportunity Announcement [FOA] No. CDC-RFA-EH21-
2102). The first two years of this ICR will extend from FY24, through
FY26, and thus will be covered for two-thirds of the ICR's three-year
approval period, while funding for the third year of this ICR will be
determined in the future. Data submission is voluntary and completed
through data sharing agreements with state agencies or their bona fide
agents.
Blood lead surveillance over the human lifespan is covered under
this single ICR, specifically for children younger than 16 years
through CBLS at NCEH, and for adults 16 years and older, through ABLES
at NIOSH. Over the past several decades there have been substantial
efforts in environmental lead abatement, improved protection from
occupational lead exposure, and a reduction in the prevalence of
population blood lead levels (BLLs) over time. The U.S. population BLLs
have substantially decreased over the last four decades. For example,
the CDC has reported the 1976-1980 U.S. mean BLL in children six months
to five years was 16.0 micrograms per deciliter (mcg/dL), and 14.1 mcg/
dL among adults 18 to 74 years. More recently, the CDC reported the
2009-2010 U.S. BLL geometric means among children ages one to five
years and among adults 20 years and older as 1.2 mcg/dL for both age
groups. In 2012, the National Toxicology Program (NTP) concluded that
there is sufficient evidence that even BLLs less than 5.0 mcg/dL are
associated with adverse health effects in both children and adults.
Despite the reduction in the
[[Page 82897]]
overall population BLL over four decades, lead exposures continue to
occur at unacceptable levels for individuals in communities and
workplaces across the nation. Surveillance will continue through CBLS
and ABLES to identify individuals with BLLs greater than most children
who may need follow-up. Surveillance can also help prioritize
communities for primary prevention of lead exposure and expanding blood
lead testing. As of October 2021, NCEH defines its Blood Lead Reference
Value (BLRV) for children at 3.5 mcg/dL. NIOSH defines an elevated BLLs
as greater than or equal to 5.0 mcg/dL for adults.
Respondents are defined as state, local, and territorial health
departments with lead poisoning prevention programs. The estimated
annual time burden for NCEH CBLS is 1,058 hours. The estimated annual
time burden for NIOSH ABLES is 280 hours. In total, CDC is requesting
approval for a total annual time burden of 1,338 hours. There is no
cost to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden Total
Type of respondents Form name Number of responses per per response burden (in
respondents respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
State, Local and Territorial CBLS Variables 66 4 4 1,056
Health Departments, or their (ASCII Text Files). 1 1 2 2
Bona Fide Agents. CBLS Aggregate
Records Form
(Excel).
ABLES Case Records 32 1 8 256
Form and Brief
Narrative Report.
ABLES Aggregate 8 1 3 24
Records Form and
Brief Narrative
Report.
----------------------------------------------------------
Total....................... ................... ........... .............. ............... 1,338
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-26085 Filed 11-24-23; 8:45 am]
BILLING CODE 4163-18-P
